Pomegranate for Anti-Inflammatory

Research suggests that pomegranate and its bioactive compounds — including punicalagins, polyphenols, tannins, and gut-derived metabolites like urolithins — demonstrate anti-inflammatory properties across a range of laboratory and preclinical studies, with proposed mechanisms including suppression of inflammatory signaling pathways such as NF-κB and MAPK, modulation of T cell activity, and reinforcement of the gut barrier. The available evidence draws primarily from cell culture experiments, animal studies, and narrative or systematic reviews, with one systematic review of 88 clinical trials finding only inconclusive support for pomegranate among functional foods when it comes to reducing inflammation in humans with chronic disease. A 2024 review specifically noted the absence of human clinical trials confirming anti-inflammaging effects, and researchers across multiple reviews consistently call for more rigorous, well-controlled human studies before firm conclusions can be drawn. Overall, the body of evidence is promising but remains largely preclinical in nature, and meaningful gaps in human trial data make it premature to draw definitive conclusions about pomegranate's effectiveness as an anti-inflammatory intervention.